Your session is about to expire
← Back to Search
Tablet-Based Cognitive Games for Mild Cognitive Impairment
N/A
Waitlist Available
Led By John Puxty, MD
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
60 years of age or older
Normal or corrected hearing and vision
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Study Summary
This trial will test whether a tablet game can improve memory and thinking skills in seniors with mild cognitive impairment, compared to tablet puzzles.
Who is the study for?
This trial is for older adults, aged 60 or above, with mild cognitive impairment. Participants must be able to use a tablet and have good vision and hearing (with aids if needed), speak English fluently, have access to a tablet for 8 weeks, and a study partner who can monitor their game play. Those on new cognitive medications or familiar with the games being tested cannot join.Check my eligibility
What is being tested?
The study aims to see if playing a role-playing game on a tablet helps improve thinking skills better than doing word or image puzzles on the same device in older adults with mild brain function issues. It also looks at which activity keeps participants more engaged over an eight-week period.See study design
What are the potential side effects?
Since this trial involves non-invasive activities like playing games on tablets, there are no direct medical side effects expected from participation. However, individuals may experience eye strain or minor physical discomfort from prolonged use of digital devices.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 60 years old or older.
Select...
My hearing and vision are normal or corrected to normal.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
attention
deductive reasoning
planning
+8 moreSecondary outcome measures
engagement
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: FarmVilleExperimental Treatment1 Intervention
tablet (iPad or android) based role-playing game (FarmVille)
Group II: puzzle gamesActive Control1 Intervention
selection of tablet (iPad or android) based word puzzles (Word Search Ultimate and Word Cookies) and image puzzles (Flow Free and Jigsaw HD)
Find a Location
Who is running the clinical trial?
Queen's UniversityLead Sponsor
365 Previous Clinical Trials
120,375 Total Patients Enrolled
John PuxtyLead Sponsor
John Puxty, MDPrincipal InvestigatorProvidence Care Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can use an iPad's touch screen without help.I started memory medication within the last 3 months.I am 60 years old or older.My hearing and vision are normal or corrected to normal.
Research Study Groups:
This trial has the following groups:- Group 1: FarmVille
- Group 2: puzzle games
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is participation in this trial still an option for potential volunteers?
"Clinicaltrials.gov confirms that this trial is not actively recruiting, as it was first posted on September 12th 2022 and has yet to be updated since then. Nevertheless, 573 other studies are still accepting patients at the current moment in time."
Answered by AI
Share this study with friends
Copy Link
Messenger